相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Semi-Mechanistic Population Pharmacokinetic/Pharmacodynamic Model of Bortezomib in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
Julie M. Janssen et al.
CLINICAL PHARMACOKINETICS (2020)
Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children's Group
Richard Aplenc et al.
HAEMATOLOGICA (2020)
Efficacy and safety of bortezomib in refractory lupus nephritis: a single-center experience
A. Segarra et al.
LUPUS (2020)
Clinical Pharmacokinetics and Pharmacodynamics of Bortezomib
Carlyn Rose C. Tan et al.
CLINICAL PHARMACOKINETICS (2019)
A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection
Farsad Eskandary et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
LC-MS/MS method for simultaneous determination of thalidomide, lenalidomide, cyclophosphamide, bortezomib, dexamethasone and adriamycin in serum of multiple myeloma patients
Chang Shu et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2016)
The use of mass spectrometry to analyze dried blood spots
Michel Wagner et al.
MASS SPECTROMETRY REVIEWS (2016)
Simultaneous analysis of anticancer agents bortezomib, imatinib, nilotinib, dasatinib, erlotinib, lapatinib, sorafenib, sunitinib and vandetanib in human plasma using LC/MS/MS
Irina Andriamanana et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2013)
Simultaneous measurement of imatinib, nilotinib and dasatinib in dried blood spot by ultra high performance liquid chromatography tandem mass spectrometry
Eva Kralj et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2012)
The analysis of dried blood spot samples using liquid chromatography tandem mass spectrometry
Brian G. Keevil
CLINICAL BIOCHEMISTRY (2011)
Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules
Wenkui Li et al.
BIOMEDICAL CHROMATOGRAPHY (2010)
Effect of the CYP3A Inhibitor Ketoconazole on the Pharmacokinetics and Pharmacodynamics of Bortezomib in Patients With Advanced Solid Tumors: A Prospective, Multicenter, Open-Label, Randomized, Two-Way Crossover Drug-Drug Interaction Study
Karthik Venkatakrishnan et al.
CLINICAL THERAPEUTICS (2009)
A new rapid micromethod for the assay of phenobarbital from dried blood spots by LC-tandem mass spectrometry
Giancarlo la Marca et al.
EPILEPSIA (2009)
Therapeutic drug monitoring of everolimus using the dried blood spot method in combination with liquid chromatography-mass spectrometry
J. van der Heijden et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2009)
Dried Blood Spot Methods in Therapeutic Drug Monitoring: Methods, Assays, and Pitfalls
Peter M. Edelbroek et al.
THERAPEUTIC DRUG MONITORING (2009)
Initial testing (stage 1) of the proteasome inhibitor bortezomib by the pediatric preclinical testing program
Peter J. Houghton et al.
PEDIATRIC BLOOD & CANCER (2008)
Determination of Morphine and 6-Acetylmorphine in Blood With Use of Dried Blood Spots
Regine Garcia Boy et al.
THERAPEUTIC DRUG MONITORING (2008)
What a drop can do: Dried blood spots as a minimally invasive method for integrating biomarkers into population-based research
Thomas W. Mcdade et al.
DEMOGRAPHY (2007)
Therapeutic drug monitoring of tacrolimus with the dried blood spot method
K. Hoogtanders et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2007)
Oxidative deboronation of the peptide boronic acid proteasome inhibitor bortezomib: Contributions from reactive oxygen species in this novel cytochrome P450 reaction
J Labutti et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2006)
Relative contributions of the five major human cytochromes P450, 1A2, 2C9, 2C19, 2D6, and 3A4, to the hepatic metabolism of the proteasome inhibitor bortezomib
V Uttamsingh et al.
DRUG METABOLISM AND DISPOSITION (2005)
Human metabolism of the proteasome inhibitor bortezomib: Identification of circulating metabolites
T Pekol et al.
DRUG METABOLISM AND DISPOSITION (2005)
Quantification of antiretroviral drugs in dried blood spot samples by means of liquid chromatography/tandem mass spectrometry
T Koal et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2005)
The development of proteasome inhibitors as anticancer drugs
J Adams
CANCER CELL (2004)
Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer
CN Papandreou et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Use of filter paper for the collection and analysis of human whole blood specimens
JV Mei et al.
JOURNAL OF NUTRITION (2001)
分享论文
